Cargando…

Temozolomide and Radiotherapy versus Radiotherapy Alone in High Grade Gliomas: A Very Long Term Comparative Study and Literature Review

Temozolomide (TMZ) is the first line drug in the care of high grade gliomas. The combined treatment of TMZ plus radiotherapy is more effective in the care of brain gliomas then radiotherapy alone. Aim of this report is a survival comparison, on a long time (>10 years) span, of glioma patients tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parisi, Salvatore, Corsa, Pietro, Raguso, Arcangela, Perrone, Antonio, Cossa, Sabrina, Munafò, Tindara, Sanpaolo, Gerardo, Donno, Elisa, Clemente, Maria Antonietta, Piombino, Michele, Parisi, Federico, Valle, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359808/ https://www.ncbi.nlm.nih.gov/pubmed/25815327 http://dx.doi.org/10.1155/2015/620643

Ejemplares similares

Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma
por: Wei, Shoufeng, et al.
Publicado: (2022)

Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis
por: Zhao, Qian, et al.
Publicado: (2016)

Intermediate neoadjuvant radiotherapy for T3 low/middle rectal cancer: postoperative outcomes of a non-controlled clinical trial
por: Bisceglia, Giovanni, et al.
Publicado: (2014)

Retracted: Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma
por: Engineering, Journal of Healthcare
Publicado: (2023)

DIPG-26. THERAPEUTIC EFFECTS OF RADIOTHERAPY WITH CONCOMITANT AND ADJUVANT TEMOZOLOMIDE VERSUS RADIOTHERAPY WITH CONCOMITANT TEMOZOLOMIDE ALONE IN CHILDREN WITH DIPG: A SINGLE-CENTER EXPERIENCE WITH 82 CASES
por: Lai, Mingyao, et al.
Publicado: (2020)

Comparison of long-term survival between temozolomide-based chemoradiotherapy and radiotherapy alone for patients with low-grade gliomas after surgical resection
por: Gai, Xiu-juan, et al.
Publicado: (2016)

Survival with concurrent temozolomide and radiotherapy in pediatric brainstem glioma with relation to the tumor volume
por: Taran, Shachi Jain, et al.
Publicado: (2015)

Modulated Radiotherapy with Concurrent and Adjuvant Temozolomide for Anaplastic Gliomas: Indian Single-center Data
por: Kataria, Tejinder, et al.
Publicado: (2017)

Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide
por: Yan, Tao, et al.
Publicado: (2011)

Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial
por: Wang, Jingjing, et al.
Publicado: (2019)

Determinants of Sensitivity to Radiotherapy in Endometrial Cancer
por: Sorolla, Maria Alba, et al.
Publicado: (2020)

Could upfront temozolomide chemotherapy postpone the need for radiotherapy in young patients with high-risk low-grade gliomas?
por: Li, Ze-Yang, et al.
Publicado: (2021)

Clinical efficacy of early postoperative intensity-modulated radiotherapy combined with Temozolomide chemotherapy in the treatment of patients with malignant glioma
por: Zhou, Hongyang, et al.
Publicado: (2022)

Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancer
por: Wallis, C J D, et al.
Publicado: (2015)

Memory in low-grade glioma patients treated with radiotherapy or temozolomide: a correlative analysis of EORTC study 22033-26033
por: Klein, Martin, et al.
Publicado: (2020)

Conventionally fractionated stereotactic radiotherapy (CFRT) in combination with dose-dense temozolomide (TMZ) in relapsed malignant glioma: A case report
por: Qie, Shuai, et al.
Publicado: (2019)

Influence of GSTP-1 Polymorphism on the Prognosis of Patients with High-Grade Glioma Who Received Temozolomide Plus Radiotherapy Adjuvant Treatment
por: Zhi, De-Bao, et al.
Publicado: (2021)

Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
por: Vieito, Maria, et al.
Publicado: (2022)

Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma
por: Faye, Mame Daro, et al.
Publicado: (2023)

Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma—A Critical Review
por: Komotar, Ricardo J., et al.
Publicado: (2008)

Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma
por: Metcalfe, Evrim, et al.
Publicado: (2016)

Radiotherapy in high grade gliomas
por: Bleehen, N.M., et al.
Publicado: (1989)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis
por: Yang, Qunying, et al.
Publicado: (2021)

Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
por: Arpa, Donatella, et al.
Publicado: (2021)

Management of dual intracranial germinoma by radiotherapy alone
por: Gupta, Rakesh, et al.
Publicado: (2015)

Urological complications after radical hysterectomy with postoperative radiotherapy and radiotherapy alone for cervical cancer
por: Li, Faping, et al.
Publicado: (2018)

Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
por: Ohno, Makoto, et al.
Publicado: (2019)

Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy
por: Dunn, J, et al.
Publicado: (2009)

Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings
por: Hilverda, Karen, et al.
Publicado: (2009)

Radiotherapy plus Concomitant Adjuvant Temozolomide for Glioblastoma: Japanese Mono-Institutional Results
por: Oike, Takahiro, et al.
Publicado: (2013)

Radiotherapy Plus Concurrent or Sequential Temozolomide for Glioblastoma in the Elderly: A Meta-Analysis
por: Yin, An-an, et al.
Publicado: (2013)

Radiotherapy plus temozolomide in elderly patients with glioblastoma: a “real-life” report
por: Biau, J., et al.
Publicado: (2017)

Effect of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy alone in nasopharyngeal carcinoma
por: OuYang, Pu-Yun, et al.
Publicado: (2016)

Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy – Results of a United Kingdom phase II trial (CNS 2007 04)()
por: Bailey, S., et al.
Publicado: (2013)

Observation of the delineation of the target volume of radiotherapy in adult-type diffuse gliomas after temozolomide-based chemoradiotherapy: analysis of recurrence patterns and predictive factors
por: Liu, Hongbo, et al.
Publicado: (2023)

Stereotactic radiotherapy for bone oligometastases
por: Colosimo, Caterina, et al.
Publicado: (2022)

Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes
por: Bovi, Joseph A., et al.
Publicado: (2020)

An Italian survey on “palliative intent” radiotherapy
por: Pergolizzi, Stefano, et al.
Publicado: (2022)

Short Interval Infield Sarcoma Development following Resection of Glioblastoma and Adjuvant Radiotherapy and Temozolomide
por: Alotaibi, Fahad E., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_o2mp23uma6v1bs76qtcgpije9c